The intersection of data and artificial intelligence forms the cornerstone of today's healthcare innovation, transforming the way we approach medical advancements. In this week’s episode, I'm excited to welcome Keshia Maughn from STATinMED, a company carving out its space with a focus on specialized data solutions in biotech. We look at the nuances of data's role in AI, the unique challenges companies face with electronic medical records, and why understanding the lifecycle of a client's needs is crucial.Keshia brings her deep expertise in navigating the complexities of a saturated market and emphasizes the importance of practicality over flash when it comes to investing in new tech.To grasp the full spectrum of how data underpins AI in biotech, tune in to our insightful discussion. Remember, clarity in data leads to precision in AI - don't miss this episode.Specifically, this episode highlights the following themes:Customization and strategic application of AI in healthcareNavigating challenges in data extraction and quality for AI integrationThe consultative approach to client partnerships in data analyticsLinks from this episode:Get to know more about Steven Swan: https://www.linkedin.com/in/swangroupGet to know more about Keshia Maughn: https://www.linkedin.com/in/keshia-maughn-mphLearn more about STATinMED: https://www.linkedin.com/in/keshia-maughn-mph

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related